Teva Receives Favorable Court Decision Regarding Seasonique(R)

Wednesday, April 7th, 2010

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. District Court for the District of Nevada has granted Teva's Motion for Summary Judgment with respect to the validity of U.S. Patent No. 7,320,969. In March 2008, Duramed, now Teva Women's Health, brought suit in the District of Nevada ...

Ark Therapeutics Files Cerepro(R) Re-Examination Documentation With The European Medicines Agency

Sunday, February 28th, 2010

Ark Therapeutics Group plc (AKT: LSE) ("Ark" or "the Company"), announces that it has filed documentation with the European Medicines Agency ("EMA") in relation to its request for re-examination of the marketing approval application ("MAA") for Cerepro®, Ark's novel gene based therapy for the treatment of operable malignant glioma (brain ...

Stocks: Don’t Expect a Super Bowl Bailout

Sunday, February 7th, 2010

Statistically, a win by either the Colts or Saints would point to market gains ahead -- which tells you all you need to know about the validity of a 'Super Bowl Effect,' says Ben Steverman